LinkedIn Icon Twitter Icon
Feb 28 – March 2, 2018
New Jersey

Speakers

Expand/Collapse

Paul Murasko
Senior Director, Multi-Channel Marketing
Sunovion Pharmaceuticals

A passionate and innovative healthcare marketing and sales leader, he is experienced in Digital Strategy, Integration and Activation.   He uses a solid understanding of the Digital Ecosystem and a commitment to not accept the status quo to drive innovative thinking and cultural change that delivers business results, achieves efficiencies, and builds a competitive advantage. Paul is currently Sr. Director of Multi-Channel Marketing for Sunovion Pharmaceuticals leading Non Personal Promotion, Digital Strategy and Execution as well as the Telesales team for Sunovion’s 6 brands.  Previously, Paul was with Johnson & Johnson primarily in the Medical Device and Diagnostics (MD&D) space.   While Director of Digital Marketing at J&J, he created DePuy’s first multi-company Digital Marketing team, led the digital integration for $19.8 billion acquisition of Synthes and was chairman of the Digital Acceleration team for the MD&D sector.

Day One

Thursday March 1, 2018

16:30 | Chair’s Closing Remarks & End of Day 1

09:00 | Chair's Opening Remarks

Day Two

Friday March 2, 2018

14:20 | Chair's Closing Remarks & End of Conference

Edward Stelmack
Senior Director, Commercial Data Management, Sales Force Operations
AstraZeneca Pharmaceuticals LP

Accomplished business-first leader with expertise setting the vision, strategy and roadmaps to deliver growth, commercial excellence and organizational alignment. Strong collaboration skills and acumen facilitate alignment across commercial functions, cross-functional partners and suppliers to deliver strategic business objectives. Catalyst for business impact and change simplifying complex opportunities for optimal engagement and influence producing significant outcomes while transforming multiple commercial programs in fast-paced matrixed cross-functional environments. 17+ Years of progressive Sales and Marketing Operational accountability specializing in Biotech and Specialty Pharma driving business value through innovation, people and technology.

Day One

Thursday March 1, 2018

15:45 | Roundtable Discussion: Refine Your Channel Recipe Through Experimenting, Testing & Rolling Put

12:00 | Panel Discussion: Setting the Scene – What are the Channels?

Dan McCormick
Director, Global Business Solutions
Amgen

Dan’s broad perspective is a culmination of experience that spans numerous sales, marketing and strategy roles where he has engaged nearly every commercial and medical function to target providers and payers in many markets.  While focused on improved US commercial effectiveness, Dan won approval for a new CoE involving the build-out of a centralized cross-portfolio sales function in which he partnered closely with suppliers to drive down costs through consolidation and risk sharing contracts.  He built a highly integrated staffing and systems infrastructure to more than double expectations by delivering a 7:1 ROI in the first 9 months while putting his organization on track to generate $200M incremental revenues over 3 years. Dan’s role has evolved to impact the broader Global organization.

Day One

Thursday March 1, 2018

12:00 | Panel Discussion: Setting the Scene – What are the Channels?

John Gallo
Executive Director, Customer Strategy and Shared Services
Sunovion Pharmaceuticals

John Gallo is currently the Executive Director of Sunovion’s Customer Strategy and Shared Services (CS3) team.  Founded in 2010, the CS3 team is a center of excellence built on maximizing the patient and HCP customer experience across the entire Sunovion portfolio of respiratory, psychiatry, and neurology therapies.  Prior to this role, John has had leadership positions in field sales, brand marketing and managed markets.

Day One

Thursday March 1, 2018

13:45 | Case Study: Blurring the Lines Between Personal & Non-Personal Promotion

Fabrizio Caranci
Director, Channel Innovation
Merck

Fabrizio Caranci is Director of Channel Innovation, part of the global Customer Engagement Capabilities CoE within Customer Strategy & Innovation group. In this role Fabrizio is responsible for the digital channels that Merck and MSD use globally to deliver superior experience to our customers such as Merck Connect, Social Media (aligned to the Enterprise Social Media Group), Mobile, eMeetings and Emerging Channels like Virtual Reality. Before joining the global team, Fabrizio was in charge of Customer Engagement, Multichannel Marketing and Business Contact Center for MSD Italy. Prior to MSD, Fabrizio was a CRM Manager in Accenture in the Life Science practice, supporting Sales & Marketing global strategy and implementation programs for major pharmaceuticals companies.

Day Two

Friday March 2, 2018

09:10 | Keynote: Looking Ahead of Disruptive Channels to Increase Engagement with Your Patients & HCPs

Matthew Balogh
Senior Director, Content Engineering
The Medicines Company

Matt Balogh is a leading Content Engineer specializing in pharmaceutical multi-channel content strategy who combines a degree in Engineering, an MBA in Marketing, and nearly three decades of coding experience to create the systems and strategies that support and inform content that change behavior. Matt is currently the Senior Director of Content Engineering, part of Content Strategy, with The Medicines Company, and former CTO of Ogilvy CommonHealth where he established and led the innovation team. He is an active speaker and hosts podcasts on martech, and marketing strategy in the healthcare industry. Matt has global experience implementing scalable, data-driven, intelligent content systems.

Day Two

Friday March 2, 2018

10:10 | Integrating Content Strategy and Content Engineering

Kyle Donaldson
Global Director – Marketing and Analytics Technology
GSK

Kyle has over 15 years experience in digital marketing and 10 years specializing in digital analytics. An avid teacher and innovator he constantly strives to find new ways to utilize data."

Day One

Thursday March 1, 2018

09:40 | Bridging the Gap Between Marketing & Commercial Insights

Buddy Scalera
Senior Director, Content Strategy
The Medicines Company

Buddy Scalera is a content strategist working in Parsippany, NJ. He his part of a team that delivers powerful, scaleable digital content strategy campaigns that deliver measurable marketing results for health and pharmaceutical brands. Formerly he was Senior Vice President of Interactive Content and Market Research at Ogilvy CommonHealth Worldwide - Interactive Marketing, an award-winning agency based in New Jersey. He is an engaging and entertaining speaker who makes it fun to learn about digital marketing, content strategy, social media marketing, mobile marketing, pharmaceutical branding, closed-loop marketing, and ebooks.

Day Two

Friday March 2, 2018

10:10 | Integrating Content Strategy and Content Engineering

Haibei Jiang
Deputy Director, Advanced Analytics
Bayer

Haibei started his career in the Pharmaceutical industry in 2008 with ZS associates. Over the years he gained experience in multiple therapeutic areas and covered various sales & marketing operations topics. His current responsibilities at Bayer include building global data, reporting and analytics solutions for the enablement of integrated multi-channel marketing solutions. His expertise also includes digital channel KPI design/reporting, business impact measurement using statistical approaches, and advanced resource allocation & budget optimization for sales and marketing investments. Haibei holds a Master’s degree of Aerospace Engineering as well as Agriculture & Biological Engineering from University of Illinois Urbana-Champaign.

Day Two

Friday March 2, 2018

09:40 | Developing a Coherent Multi-Channel Plan Across the Globe?

Sandy Donaldson
Head of Global Omnichannel Operations
UCB

Sandy Donaldson is globally responsible of Omnichannel Operations at UCB with a focus on the US. His 10 year span at UCB has included roles in Corporate Strategy, Business Operations, Product Launch and Digital Enablement. Today, his teams support the various UCB brands in creating innovative and value added campaigns for stakeholders and patients. Sandy started his career in Medical Device development at Avery Dennison, successfully bringing various wound care and surgical products to market.

Day One

Thursday March 1, 2018

12:00 | Panel Discussion: Setting the Scene – What are the Channels?

09:10 | Case Study: How & Why UCB Puts Patients First – The Move to Create Better Solutions with Omni-Channel

Dale Benner
Senior Director, Product Management
DMD

With more than 20 years in the healthcare and pharmaceutical industry, Dale Benner is the Senior Director, Product Management at DMD, where he plays a key role in DMD’s growing portfolio of digital identification products. Dale has launched pharmaceutical and information services products, and has expertise in a broad range of healthcare areas including product management, strategic planning, supply chain, multi-channel marketing, forecasting, and business development. Previously, Dale was Director, Market Planning at LexisNexis Healthcare. Prior to that, Dale was Director, Solutions Management at TGaS Advisors. Dale also served in Product Management positions at IMS for 12 years. Dale holds an MBA from Regis University and a Certificate in Pharmaceutical Management from Rutgers Business School.

Day One

Thursday March 1, 2018

11:30 | Spotlight Talk: Optimizing the HCP Digital Channel – Looking Beyond Your Own Websites

Igor Rudychev
Senior Business Insights Director
AstraZeneca

Igor Rudychev is currently a Senior Business Insight Director with AstraZeneca. Prior to this he was the Director of Commercial Analytics, Resource Allocation Team Leader at Pfizer. Igor has 20+ years of the analytics experience and for the last 15 years he has been specializing in the Pharmaceutical Data Analytics, Patient-Level Data (APLD), Sales & Marketing Analytics, Resource Allocation & Optimization, Brand Analytics, and  Forecasting. Prior to joining Pfizer, Igor was a Vice President of Operations with Bayser, Management Consulting firm in Chicago, where he provided strategic and analytical insights to the top 20 global pharmaceutical companies. Igor has an MBA from the University of Chicago Booth School of Business and PhD in Theoretical Physics (Superstring Theory & Black Holes) from Texas A&M University.

Don DeStefano
VP, Business Development Sales
LexisNexis Risk Solutions

Don is the Vice President of Business Development, and is responsible for the overall performance of the LexisNexis claims-based solutions. Don has over 20 years of experience in the health care industry, spanning roles in market research, sales, and account management. At LexisNexis, Don has responsibilities for business development and account management. He works with pharmaceutical, biotech, and medical device companies, as well as other health care-related organizations, to provide strategic consulting and information solutions to sales, commercial operations, and marketing, across the full range of LexisNexis Market Intelligence solutions. Prior to joining LexisNexis, Don was Sales Director at IMS Health, one of the world’s largest data and information companies in the pharmaceutical and healthcare industry. In this role, he supported numerous clients across multiple segments, including pharmaceutical and biotech companies, ad agencies, government agencies, consulting firms, and other health care-related organizations. Don holds a BS in Business from Stockton University, and an MBA in Pharmaceutical Marketing from St. Joseph’s University.

Day One

Thursday March 1, 2018

14:15 | Spotlight Talk: Precise Targeting in Pharma to Survive in the Competitive Healthcare Landscape

Broderick Jones
Executive Director
EPAM Systems

Broderick is the Executive Director at EPAM Systems with extensive Healthcare & Life Science Industry experience focused on Business Strategy, Digital, and Intelligent Enterprise with the intent to partner with the world’s leading companies to imagine, design, and engineer solutions and customer experiences that transform business. Prior to joining EPAM, Broderick was the Managing Director at Accenture helping clients with commercial analytics with the goal of driving top-line growth and building capabilities for ongoing commercial success and cost management.

Day Two

Friday March 2, 2018

11:40 | Omni-Channel on the Edge

Qi Feng
Assistant Director, Marketing Analytics
Astellas

Qi is currently the Assistant Director of Oncology Marketing Analytics at Astellas Pharma, providing analytical support for all promotional tactics. Prior to this, Qi was the VP of Consulting Services at The Nielsen Company, specializing in promotional response models, ROI measurement and budget optimization. Clients include CPG, retail, direct selling company and automakers.

Day Two

Friday March 2, 2018

11:50 | Measuring Attributions & ROIs through Dissecting the Intrinsic Channels' Relationships

Erik Poole
Director of Product, Digital Marketing
Zoetis

Day Two

Friday March 2, 2018

13:50 | How Are You Doing? Impact Measurement for ROI of Your Channel Tactics

Jaisri Chety
Director, Global Multichannel Data Strategy & Management
GSK

Day Two

Friday March 2, 2018

13:20 | The Foundation of Successful Multi-Channel Strategy & Customer Engagement – Data Insights

Adam Hadjinian
GM – West Coast
Qral Group

Adam has dedicated >15 years focusing on global pharmaceutical & biotech product commercialization.  Broad experience across all elements of the product life cycle, including asset evaluation, commercial operations, finance & strategy, and in-line US brand marketing. At Qral Group, Adam has focused on ultra-orphan commercialization issues – working closing with clients in New Product Planning, Launch, In-line Brand Marketing, and Commercial Operations.

Fonny Schenck
CEO
Across Health

Fonny (°1963) joined Across Group as a managing partner in August 2007 and subsequently took the CEO position at Across Health. He joined from Johnson & Johnson, where he led the European programmes for salesforce effectiveness, CRM business strategy and digital, and played a key role in the Marketing Excellence programme. Fonny received many awards at J&J for his achievements in the CRM and digital space, both at European and global level. In addition, he is a well-known thought leader, trainer, speaker at international events, and has authored several strategic articles on these topics.

Ruud Kooi
Managing Partner
Across Health

Ruud Kooi has worked in pharma for over 20 years. Ruud started his career at Janssen (J&J) and was part of the first digital and multichannel teams. Since 12 years, Ruud is working as co-founder for Across Health, where he leads global pharma companies in their change and development journeys from single channel to multichannel to omnichannel. Ruud is an experienced omnichannel strategy leader with a passion for measuring campaign performance and outcome results. Ruud facilitates, challenges and leads global, regional and local brand teams in strategy workshops to create an ambitious but realistic omnichannel plan for the next years. As a standard practice within Across Health, Ruud and his delivery teams (co-)implement and coach the same brand teams in the execution of the plans and help to close to business case as well. Using the Across Health omnichannel navigator 3.0 data, Ruud quantifies campaign ambitions as well as the planned campaign programs to validate the SOV is in line with the set market demands and competitor analysis. Building upon initial omnichannel successes, Ruud works to continuously refine the brand ambitions to the next level.

Day One

Thursday March 1, 2018

15:15 | How to Move from Channel-Centric MCM to Full Omnichannel HCP Engagement

Ryan Bruskiewicz
GM – Central
Qral Group

Ryan has 10+ years of consulting and analytics experience in pharma and biotech, with a focus on analytical application development and commercial analytics, including optimization of sales, marketing, and access resource allocation. At Qral Group, Ryan has been excited about the opportunity to work with such a talented group of teammates, create new approaches and solutions to solve our clients’ challenges leveraging the latest advances in data and analytical tools.  I enjoy that clients engage us to solve some of their most challenging problems. Clients recognize that we are able to engage in a different way – they view our experienced consultants as extensions of their team and trusted advisors.